May 9, 2022 01:01 PM EDTUpdated May 10, 08:44 AM
Pharma
Law

Il­lu­mi­na forced to pay al­most $334M as it los­es DNA se­quenc­ing patent case

Tyler Patchen

News Reporter

A fed­er­al ju­ry in Delaware on Fri­day or­dered Il­lu­mi­na to pay Com­plete Ge­nomics Inc., a sub­sidiary of the BGI Group, the world’s largest mak­er of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times